Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: A dynamic balance

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 87-92

  Volpert, O V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Angiogenesis; Apoptosis; Endothelial cell survival; Thrombospondin 1

Indexed keywords

ANGIOGENESIS INHIBITOR; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL SURVIVAL; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GROWTH INHIBITION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; CELL SURVIVAL; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSPONDIN 1;

EID: 0034535778     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026560618302     Document Type: Review

References (46)

1. How tumors become angiogenic
2. Is tissue mass regulated by vascular endothelial cells? Prostate as the first evidence
3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
4. Blood vessel formation: What is its molecular basis?
5. Establishing a link between oncogenes and tumor angiogenesis
6. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
7. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways
8. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
9. Angiogenesis: How a tumor adapts to hypoxia
10. p53 Inhibits hypoxia-inducible factor-stimulated transcription
11. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
12. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
13. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
14. Thrombospondin as an inhibitor of angiogenesis
15. Expression of the extracellular matrix molecule thrombosypondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines
16. Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1
17. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene
18. Myb-dependent regulation of thrombospondin 2 expression. Role of mRNA stability
19. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun
20. Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1
21. Thrombospondin as a regulator of angiogenesis
22. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
23. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
24. Activation of stress-activated protein kinase/c-Jun NH2-terminal kinase and p38 kinase in calphostin C-induced apoptosis requires caspase-3-like proteases but is dispensable for cell death
25. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
26. Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance
27. Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21(Cip1/WAF1)
28. Thrombospondin-1 is a major activator of TGF-beta1 in vivo
29. Tumour suppressor genes and angiogenesis: The role of TP53 in fibroblasts
30. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression
31. Multiple forms of angiostatin induce apoptosis in endothelial cells
32. Endostatin induces endothelial cell apoptosis
33. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth
34. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta(12,14)-prostaglandin J(2)
35. Oxidized LDL activates fas-mediated endothelial cell apoptosis
36. Angiostatin binds ATP synthase on the surface of human endothelial cells
37. Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding
38. VEGF deprivation-induced apoptosis is a component of programmed capillary regression
39. Release of bFGF, an endothelial cell survival factor, by osmotic shock
40. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells
41. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
42. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin αVβ3, promotes endothelial cell survival, and induces angiogenesis in vivo
43. NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival
44. Linking extracellular survival signals and the apoptotic machinery
45. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression
46. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells